PTEN Nuclear Localization Is Regulated by Oxidative Stress and Mediates p53-Dependent Tumor Suppression
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The tumor suppressor gene PTEN (phosphatase and tensin homologue deleted on chromosome 10) is frequently mutated or deleted in various human cancers. PTEN localizes predominantly to the cytoplasm and functions as a lipid phosphatase, thereby negatively regulating the phosphatidylinositol 3-kinase-AKT signaling pathway. PTEN can also localize to the nucleus, where it binds and regulates p53 protein level and transcription activity. However, the precise function of nuclear PTEN and the factors that control PTEN nuclear localization are still largely unknown. In this study, we identified oxidative stress as one of the physiological stimuli that regulate the accumulation of nuclear PTEN. Specifically, oxidative stress inhibits PTEN nuclear export, a process depending on phosphorylation of its amino acid residue Ser-380. Nuclear PTEN, independent of its phosphatase activity, leads to p53-mediated G(1) growth arrest, cell death, and reduction of reactive oxygen species production. Using xenografts propagated from human prostate cancer cell lines, we reveal that nuclear PTEN is sufficient to reduce tumor progression in vivo in a p53-dependent manner. The data outlined in this study suggest a unique role of nuclear PTEN to arrest and protect cells upon oxidative damage and to regulate tumorigenesis. Since tumor cells are constantly exposed to oxidative stress, our study elucidates the cooperative roles of nuclear PTEN with p53 in tumor suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Under oxidative stress, PTEN accumulates in the nucleus and can bind to p53, amplifying its function [89], [90].”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Chung, J.-H., Ginn-Pease, M. E., & Eng, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0124 · Cited by 164
RetractedChung, J.-H., Ostrowski, M. C., Romigh, T., Minaguchi, T., Waite, K. A., & Eng, C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl177 · Cited by 112
RetractedLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,297
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Crystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Self-citationThe Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Self-citation
Research works printed but not linked: 4
- Adey N. B., 2000, Cancer Res., 60, 35
- Ginn-Pease M. E., 2003, Cancer Res., 63, 282
- Maehama T., 2000, Tanpakushitsu Kakusan Koso, 45, 2405
- Mutter G. L., 2000, J. Clin. Endocrinol. Metab., 85, 2334
Cited by
Items 101–162 of 162
Du, Z., Dong, C., & Ren, J. (2017) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/aa6b07 · Cited by 11
Assinder, S. J., Dong, Q., Mangs, H., & Richardson, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.053066 · Cited by 8
Non‐Cell Autonomous or Secretory Tumor Suppression
Chua, C. E. L., Chan, S. N., & Tang, B. L. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24574 · Cited by 9
Kang, K. A., Piao, M. J., Fernando, P. D. S. M., Herath, H. M. U. L., Boo, H., Yoon, S. P., & Hyun, J. W. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-04944-0 · Cited by 7
The oncogenic role of microRNA‑500a in colorectal cancer
Li, Y., & Chen, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11291 · Cited by 9
From adrenarche to aging of adrenal zona reticularis: precocious female adrenopause onset
Nunes-Souza, E., Silveira, M. E., Mendes, M. C., Nagashima, S., de Paula, C. B. V., Silva, G. G. V. C., Barbosa, G. S., Martins, J. B. B., de Noronha, L., Lenzi, L., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0416 · Cited by 8
Сергеевна, Ч. Е., Каменков, С. С., Chechekhin, V. I., Zinoveva, A., Bakhchinyan, E., Efimenko, A. Y., Kalinina, N., Va, T., Kulebyakin, K. Y., & Tyurin‐Kuzmin, P. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157164 · Cited by 6
MicroRNA-21 and microRNA-148a affects PTEN, NO and ROS in canine leishmaniasis
de Freitas, J. H., Bragato, J. P., Rebech, G. T., Costa, S. F., dos Santos, M. O., Soares, M. F., Eugênio, F. D. R., dos Santos, P. S. P., & de Lima, V. M. F. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1106496 · Cited by 7
The Optimization of Soluble PTEN Expression in Escherichia coli
Nazarali, A. J., Ji, S., Hu, Y., An, Y., Fang, N., Li, Y., & Jin, H. (2015) · The Open Biochemistry Journal · doi:10.2174/1874091x01509010042 · Cited by 6
Waniczek, D., Śnietura, M., Pigłowski, W., Rdes, J., Kopeć, A., Młynarczyk-Liszka, J., Rudzki, M., Hudyka, K., Arendt, J., & Lange, D. (2012) · Współczesna Onkologia · doi:10.5114/wo.2012.30059 · Cited by 6
The PTEN/PI3 Kinase Pathway in Human Glioma
Stokoe, D., & Furnari, F. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-553-8_15 · Cited by 6
Ruscetti, M. A., & Wu, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_4 · Cited by 8
Self-citationTait, I., Li, Y., & Lu, J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1999 · Cited by 6
Venegas, J. A., Onur, O. E., Kang, S. C., Hitomi, M., & Eng, C. (2025) · Endocrine Related Cancer · doi:10.1530/erc-24-0216 · Cited by 5
Yanes‐Diaz, J., Palao‐Suay, R., Camacho, F. I., Riestra‐Ayora, J., Aguilar, M. R., Fernández, R. S., & Sánchez‐Rodríguez, C. (2025) · Drug Delivery · doi:10.1080/10717544.2024.2449376 · Cited by 5
Zheng, Y., Yu, K., Lin, J., Liang, Z., Zhang, Q., Li, J., Wu, Q., He, C., Mei, L., Zhao, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57858-8 · Cited by 5
Igarashi, A., Kato, T., Sesaki, H., & Iijima, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.081 · Cited by 5
Does PTEN gene mutation play any role in Li-Fraumeni syndrome.
Akouchekian, M., Hemati, S., Jafari, D., Jalilian, N., & Manshadi, M. D. (2016) · PubMed Central · Cited by 11
10-gingerol induces oxidative stress through HTR1A in cumulus cells: in-vitro and in-silico studies
Kiptiyah, K., Widodo, W., Ciptadi, G., Aulanni’am, A., Widodo, M. A., & Sumitro, S. B. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0042 · Cited by 5
Involvement of PTEN in TPA‐mediated p53‐activation in mouse skin epidermal JB6 cells
Robbins, D. F., Ponville, J., Morris, K., & Zhao, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.10.036 · Cited by 4
Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition
Wu, J., Tsai, H., Hsiao, Y.-H., Wu, J.-S., Wu, C., & Tai, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020681 · Cited by 4
Essence of PTEN: a Broad-Spectrum Therapeutic Target in Cancer
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac112.95879603 · Cited by 5
PTEN-Associated Complexes: An Overview.
Mosessian, S., & Wu, H. (2010) · PubMed · Cited by 3
Self-citationKovacic, P., & Somanathan, R. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0730-0_12 · Cited by 3
Miyata, S., Wang, L., & Kitanaka, S. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.08.007 · Cited by 4
Hints from a Female Patient with Breast Cancer Who Later Presented with Cowden Syndrome
Wang, W.-C., Hou, T., Kuo, C., & Lai, Y. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e25 · Cited by 3
Energy needs and problems in the Sahelian and Sudanese zones: prospects of solar power
Moumouni, A. (1973) · AMBIO · Cited by 3
Zhou, X., He, S., He, J., Xiong, Y., Hu, Z., Xian, H., Guo, G., Tan, S., Ouyang, D., Liu, R., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117120 · Cited by 2
Das, P., Pal, S., Das, N. K., Chakraborty, K., Chatterjee, K., Mal, S., & Choudhuri, T. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1062462 · Cited by 1
Nakhaee, N., Zeinali, S., Kabiri, M., & Teimoori‐Toolabi, L. (2025) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.43371 · Cited by 1
Kluth, M., Plage, H., Furlano, K., Hofbauer, S. L., Weinberger, S., Fendler, A., Ralla, B., Schallenberg, S., Elezkurtaj, S., Lennartz, M., et al. (2026) · Genes Chromosomes and Cancer · doi:10.1002/gcc.70105 · Cited by 1
Fiuji, H., & Nassiri, M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100895 · Cited by 1
Soylu, H., Aksu, K., Üstünel, İ., Karaçor, K., & Beyazçiçek, Ö. (2023) · Sağlık Bilimlerinde Değer · doi:10.33631/sabd.1125407 · Cited by 1
The role of 8q amplification and microRNAs in prostate cancer
Jalava, S. E. (2012) · Tampere University Institutional Repository (Tampere University)
Tait, I. (2014) · Tuwhera (Auckland University of Technology)
Drug resistance mechanisms in a high grade glioma cell line
Al-Ghafari, A. B. (2013) · Nottingham ePrints (University of Nottingham)
Análise histológica e imuno-histoquímica de leiomiomas e leiomiossarcomas de boca
Prieto-Oliveira, P. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.23.2012.tde-13042013-114813
The role of the tumor suppressor PTEN in bone homeostasis
Arsenault, M. G. (2008) · eScholarship@McGill (McGill) · doi:10.82308/12655
dos Santos, A. C. F., & dos Santos (2012)
Phosphatidylinositol Turnover and Receptors
Ramazzotti, G., Billi, A. M., Faenza, I., & Cocco, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.98578-7
Oliveira, A. C. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2016.tde-27072016-143803
Chapter 6 Plumbagin and Prostate Cancer Therapy
Reshma, R. S., Nadhan, R., & Srinivas, P. (2016) · Traditional herbal medicines for modern times · doi:10.1201/9781315370156-7
Mechanism of action of ID4 as a tumor suppressor
Komaragiri, S. K. (2016) · Atlanta University Center Robert W. Woodruff Library (Atlanta University Center Robert W. Woodruff Library)
ASPECTOS GENÉTICOS RELACIONADOS AO CÂNCER DE MAMA
Germano, A. B. D. S. B., & de Lima, F. C. V. (2021) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-88958-10-0/47-86
Heng, H., Ing, Z. D., Rennan, C. B., & Hin, L. C. (2008)
Health Sciences Research Commons
Bao, W., Florea, L., Wu, N., Zhao, W., & Banaudha, K. K. (2014)
Phosphatase and tensin homolog deleted in chromosome 10
Koltai, T., Reshkin, S. J., Baltazar, F., & Fliegel, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90528-2.00014-x
Salmena, L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736282199.793580834
Masse, I., Molin, L., Mouchiroud, L., Vanhems, P., Palladino, F., Billaud, M., & Solari, F. (2009) · PLoS ONE · doi:10.1371/annotation/8b010ad6-34d5-45fc-9bc2-c82a7370ebc7
Day, E. K., Zhong, Q., Purow, B. W., & Lazzara, M. J. (2023) · doi:10.1158/0008-5472.c.6512959.v1
Zeng, N., Li, Y., He, L., Xu, X., Galicia, V. A., Deng, C., & Stiles, B. L. (2023) · doi:10.1158/1541-7786.c.6542160
Zeng, N., Li, Y., He, L., Xu, X., Galicia, V. A., Deng, C., & Stiles, B. L. (2023) · doi:10.1158/1541-7786.c.6542160.v1
The Nuclear Face of PTEN : Implications in Cancer Prognosis and Targeted Therapy
Ghosh, M. K., Chakraborty, S., Karmakar, S., & BASU, M. N. (2026) · BioFactors · doi:10.1002/biof.70072
Dérégulation de MYC dans les Leucémies Aiguës Lymphoblastiques T
Bonnet, M. (2011) · theses.fr (ABES) · doi:10.70675/155c08ffz3d83z4d03zb503z2fa5305b47d6
Hagege, A. (2022) · theses.fr (ABES) · doi:10.70675/de357a08zde04z4690z8b75z8f2bd3f595b4
Etude du rôle des espèces réactives de l'oxygène dans le développement du pancréas
Hoarau, E. (2015) · theses.fr (ABES) · doi:10.70675/30630970z6f5az40e5zb0d7z40d64f0a3373
Aspartic Acid 386 Negatively Regulates Nuclear Translocation of PTEN
Kato, T., Ohtsuki, Y., Mitani, M., & Fujita, M. (2026) · Genes to Cells · doi:10.1111/gtc.70155
Benton, G. (2010) · DigitalGeorgetown (Georgetown University Library)
AVALIAÇÃO DA EXPRESSÃO PROTEICA DE PTEN, MDM2, P53 E AR EM LESÕES PROLIFERATIVAS DA PRÓSTATA CANINA
Calderón, R., & Gabriel, L. (2014) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences
Metadata
- Authors
- Chang, C.-J., Mulholland, D. J., Valamehr, B., Mosessian, S., Sellers, W. R., & Wu, H.
- Affiliations
- University of California, Los Angeles (US)
- Harvard University (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-05-01
- Volume
- 28
- Issue
- 10
- Pages
- 3281-3289
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2423144
- OpenAlex
- W2131234404
- Cited by
- 155
- References
- 41
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 11 · 2022: 3 · 2021: 6 · 2020: 12 · 2019: 7 · 2018: 3 · 2017: 9 · 2016: 8 · 2015: 7 · 2014: 20 · 2013: 12 · 2012: 11
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health (NIH P50, CA86306)
- U.S. Public Health Service
- National Cancer Institute (P50 CA86306, CA 092131, CA107166:01S1, CA86306, R01CA107166, P50CA086306, F32CA112988, P50CA092131, CA107166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- PTEN, nuclear localization, oxidative stress, p53, tumor suppression, nuclear export, G1 cell cycle arrest, reactive oxygen species, prostate cancer, phosphatidylinositol 3-kinase/Akt signaling
- MeSH terms
- Animals, Base Sequence, Cell Cycle, Cell Nucleus, Cells, Cultured, Humans, Male, Models, Biological, Neoplasm Transplantation, Prostatic Neoplasms, Transplantation, Heterologous, Genes, p53, Tumor Suppressor Protein p53, Mice, SCID, Apoptosis, DNA Primers, Mice, Knockout, Oxidative Stress, Active Transport, Cell Nucleus, Cell Line, Tumor, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.